/Investor DB

Seventure Partners — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

Animabanimab.comOct 2020✓ verified

Animab develops proprietary antibodies that mimic natural intestinal protection mechanisms to safeguard piglets' health during post-weaning, a critical period in livestock production.

AgTechBiotechDeep TechHealthtechGhent, BE

Vikram Virdi(Chief Science Officer & Scientific Co-Founder)inAnn DepickerNico CallewaertEric CoxHenri De GreveAlain Wille(CEO)in

Co-investorsAgri Investment FundPMVQbic FundV-Bio VenturesAIFVIB

Citryllcitryll.cominSeries B · Jul 2020 · $21M✓ verified

Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones.

BiotechHealthtechMedical DevicesOss, NL

Renato Chirivi(Co-founder (former CSO))in

BoardPaul Peter Tak(Chair of the Board)

Co-investorsBioGeneration VenturesPureos BioventuresForbionJohnson & Johnson Innovation – JJDCBOMCurie Capital+1 more

Myco Technologymycoiq.cominJun 2020 · $39M

MycoTechnology develops food and beverage ingredients using mushroom mycelial fermentation, creating flavor modulation and sugar-reduction solutions for formulators, chefs, and R&D professionals.

BiotechFoodTechNew MaterialsAurora, US

Brooks Kelly(Director)Alan Hahn(Board Member & Co-Founder)in

BoardPeter Lubar(Director)Sanjeev Krishnan(Director)Scott Horner(Director)inEphraim Lindenbaum(Director)

Co-investorsBloom8Cerity Partners VenturesCIBUS ENTERPRISE FUND II LPDAO JonesEvolution VC PartnersGaingels+14 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.